deal

Pharma

Sanofi is offloading 17 meds from its pain and CNS rosters

Sanofi is selling off another clutch of established meds, in a move consistent with CEO Paul Hudson’s “play to win” strategy.
Fraiser Kansteiner Jul 12, 2022 9:13am

Collaboration in biopharma is 'alive and well,' panel says

Jan 19, 2022 11:15am

Novartis launches $15B share buyback campaign

Dec 16, 2021 10:20am

Large pharmas will have $1.7T M&A firepower next year: analyst

Dec 1, 2021 11:05am

Pharma deal values plummet 56% due to COVID-19: report

Jul 23, 2020 3:30pm

BMS' management overhaul continues as development chief bolts

Dec 13, 2019 10:59am